🇺🇸 FDA
Patent

US 12310986

Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxidative stress

granted A61KA61K31/375A61K33/36

Quick answer

US patent 12310986 (Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxidative stress) held by The Board of Regents of the University of Texas System expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/375, A61K33/36, A61P, A61P35/00